| |
Company
Roster
|
|
Total
Insiders : |
22 |
|
|
|
Total
Direct Shares :
|
1,274,838 |
|
|
Total
Indirect Shares :
|
7,086,541 |
| |
%
Held by Insiders:
|
1.19% |
|
|
| |
| Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
  Kalofonos Isabel |
Chief Commercial Officer |
2026-01-05 |
834 |
2026-01-05 |
0 |
| Betz Stephen F. |
Chief Scientific Officer |
2025-12-26 |
117,713 |
|
0 |
| Struthers Richard Scott |
President & CEO, Director |
2025-12-18 |
364,759 |
2025-12-18 |
978,205 |
| Pizzuti Dana |
Chief Med and Dev Officer |
2025-12-01 |
66,837 |
2022-10-10 |
0 |
| Fust Matthew K |
Director |
2025-09-26 |
22,836 |
2019-12-16 |
0 |
| Deardorf Caren |
|
2025-06-11 |
16,300 |
2023-06-16 |
0 |
| Wierenga Wendall D |
|
2025-06-11 |
116,146 |
2020-04-28 |
0 |
| Bedrosian Camille L |
|
2025-06-11 |
16,300 |
2023-06-16 |
0 |
| Nichols Weston |
|
2025-06-11 |
16,300 |
2023-06-16 |
0 |
| Vivaldi Coelho Rogerio |
|
2025-06-11 |
21,300 |
2023-06-08 |
0 |
| Okey Stephanie |
|
2025-06-11 |
16,300 |
2023-06-16 |
0 |
| Knight Jeff E. |
|
2025-03-19 |
87,491 |
2022-02-28 |
0 |
| Schilke Tobin |
|
2025-03-10 |
52,000 |
2025-03-10 |
0 |
| Wilson Marc |
|
2024-09-26 |
111,092 |
2022-02-28 |
0 |
| Hassard James |
|
2024-07-05 |
29,259 |
2023-03-01 |
0 |
| Krasner Alan Seth |
Chief Medical Officer |
2023-10-17 |
43,210 |
2018-07-20 |
0 |
| Madan Ajay |
Chief Development Officer |
2022-03-01 |
176,995 |
|
0 |
| Vivo Capital Surplus Fund Viii, L.p. |
10% Owner |
2020-04-03 |
0 |
2020-04-17 |
298,625 |
| Versant Ventures V (canada), L.p. |
10% Owner |
2019-02-04 |
0 |
2019-02-04 |
0 |
| Schwab Andrew J. |
Former 10% holder |
2018-07-20 |
0 |
2019-06-21 |
94,489 |
| Vivo Opportunity Fund, L.p. |
10% Owner |
2018-07-20 |
0 |
2020-03-09 |
168,165 |
| Edelman Joseph |
10% Owner |
2018-07-20 |
0 |
2022-04-18 |
5,321,032 |
| Versant Venture Capital V (canada), Lp |
10% Owner |
2018-07-20 |
0 |
2018-07-20 |
226,025 |
|
|
7.39 (16.08%) 
